Covered recipient · General Payments record
KATHLEEN STAUNTON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$886.15
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $260.04 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $88.99 | 5 |
| GlaxoSmithKline, LLC. | $61.82 | 4 |
| ABBVIE INC. | $37.06 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $33.42 | 2 |
| Lilly USA, LLC | $19.97 | 1 |
| Biocon Biologics Inc | $18.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.64 | 04/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108247532 | CMS |
| ABBVIE INC. | $18.42 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108247534 | CMS |
| Biocon Biologics Inc | $18.78 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154784562 | CMS |
| GlaxoSmithKline, LLC. | $16.40 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116712039 | CMS |
| GlaxoSmithKline, LLC. | $13.49 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116642810 | CMS |
| GlaxoSmithKline, LLC. | $16.93 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116447576 | CMS |
| GlaxoSmithKline, LLC. | $15.00 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116706707 | CMS |
| Lilly USA, LLC | $19.97 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135729183 | CMS |
| Novo Nordisk Inc | $18.68 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100234538 | CMS |
| Novo Nordisk Inc | $16.90 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100471355 | CMS |
| Novo Nordisk Inc | $17.58 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100345088 | CMS |
| Novo Nordisk Inc | $17.13 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100650073 | CMS |
| Novo Nordisk Inc | $18.70 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100497127 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.35 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137828401 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.07 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137828403 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.